Status:
COMPLETED
Human Metabolic Flexibility: Its Role in Energy Regulation and Obesity
Lead Sponsor:
Singapore Institute of Food and Biotechnology Innovation
Conditions:
Metabolic Flexibility
Eligibility:
All Genders
21-35 years
Phase:
NA
Brief Summary
Obesity is commonly described as a consequence of excess calorie intake. Conventionally, the physiological variables that have been of extensive interest are food intake and energy expenditure. Despit...
Detailed Description
Obesity is commonly described as a consequence of excess calorie intake. Conventionally, the physiological variables that have been of extensive interest are food intake and energy expenditure. Despit...
Eligibility Criteria
Inclusion
- Chinese Male or Female
- Age between 21-35 years
- Body mass index 17.5-32.0 kg/m2
Exclusion
- People with major chronic disease such as heart disease, cancer or diabetes mellitus
- People with family history of diabetes
- People who have intolerances or allergies to study foods
- Individuals who are taking drugs known to affect glucose metabolism, body fat distribution, appetite, food intake or energy metabolism
- Individuals who are on a special diet or recently on a weight-lost diet
- Pregnant women
Key Trial Info
Start Date :
May 19 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2017
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04773132
Start Date
May 19 2015
End Date
December 11 2017
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition Research Centre
Singapore, Singapore, 117599